Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sulijia plus NP in Advanced NSCLC
NCT03117335Phase 3Completed
- Sponsor
- Jiangsu Wuzhong Pharmaceutical
- Start
- Nov 2011
- Primary completion
- Nov 2016
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of endostar in non-small cell lung cancer (NSCLC), sponsored by Jiangsu Wuzhong Pharmaceutical. Started Nov 2011; status: completed.
02
Drugs
endostar
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT03117335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03117335.